COX-1 and COX-2 Expression in Feline Oral Squamous Cell Carcinoma

Journal of Comparative Pathology

Volumn 135, Issue 2-3, 2006, Pages 93-99

  Hayes, A ^a   Scase, T ^a   Miller, J ^a   Murphy, S ^a   Sparkes, A ^a   Adams, V ^a  

^a ANIMAL HEALTH TRUST   (United Kingdom)

Author keywords

cat; Cox 1 and 2; cyclooxygenase; oral squamous cell carcinoma; tumour

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; EPITOPE; POLYCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL DISEASE; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CAT; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MOUTH CARCINOMA; MOUTH MUCOSA; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CAT DISEASES; CATS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; IMMUNOHISTOCHEMISTRY; MOUTH MUCOSA; MOUTH NEOPLASMS;

FELIDAE;

EID: 33748897593     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2006.06.001     Document Type: Article

References (49)

1. Andrews, L.K. (1987). Tumours of the alimentary system. In: Diseases of the Domestic Cat: Medicine and Surgery, Vol. 1, J. Holzworth, Ed., W.B. Saunders, Philadelphia, pp. 486-489.
2. Atkins D., Reiffen K.A., Tegtmeier C.L., Winther H., Bonato M.S., and Storkel S. Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. Journal of Histochemistry and Cytochemistry 52 (2004) 893-901
3. Beam S.L., Rassnick K.M., Moore A.S., and McDonough S.P. An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Veterinary Pathology 40 (2003) 496-500
4. Boria P.A., Murry D.J., Bennett P.F., Glickman N.W., Snyder P.W., Merkel B.L., Schlittler D.L., Mutsaers A.J., Thomas R.M., and Knapp D.W. Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs. Journal of the American Veterinary Medical Association 224 (2004) 388-394
5. Chan G., Boyle J.O., Yang E.K., Zhang F., Sacks P.G., Shah J.P., Edelstein D., Soslow R.A., Koki A.T., Woerner B.M., Masferrer J.L., and Dannenberg A.J. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Research 59 (1999) 991-994
6. Dore M., Lanthier I., and Sirois J. Cyclooxygenase-2 expression in canine mammary tumors. Veterinary Pathology 40 (2003) 207-212
7. Dorn C.R., and Priester W.A. Epidemiological analysis of oral and pharyngeal cancer in dogs, cats, horses and cattle. Journal of the American Veterinary Medical Association 169 (1976) 1202-1206
8. Gallo O., Masini E., Bianchi B., Bruschini L., Paglierani M., and Franchi A. Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Human Pathology 33 (2002) 708-714
9. Giovannucci E., Egan K.M., Hunter D.J., Stampfer M.J., Colditz G.A., Willett W.C., and Speizer F.E. Aspirin and the risk of colorectal cancer in women. New England Journal of Medicine 333 (1995) 609-614
10. Giovannucci E., Rimm E.B., Stampfer M.J., Colditz G.A., Ascherio A., and Willett W.C. Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Annals of Internal Medicine 121 (1994) 241-246
11. Gupta S., Srivastava M., Ahmad N., Bostwick D.G., and Mukhtar H. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 42 (2000) 73-78
12. Gupta R.A., Tejadam L.V., Tong B.J., Das S.K., Morrow J.D., Dey S.K., and DuBois R.N. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Research 63 (2003) 906-911
13. Harris R.C., McKanna J.A., Akai Y., Jacobson H.R., Dubois R.N., and Breyer M.D. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. Journal of Clinical Investigation 94 (1994) 2504-2510
14. Henry C.J., McCaw D.L., Turnquist S.E., Tyler J.W., Bravo L., Sheafor S., Straw R.C., Dernell W.S., Madewell B.R., Jorgensen L., Scott M.A., Higginbotham M.L., and Chun R. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clinical Cancer Research 9 (2003) 906-911
15. Hillman L.A., Fan T.M., de Lorimer L.P., Charney S.C., Heller D.A., Barger A.M., and Sprandel I.T. Effects of COX-2 inhibition on PGE2 and VEGF in a feline oral squamous cell carcinoma cell line. Journal of Veterinary and Comparative Oncology 3 (2005) 151
16. Hwang D., Scollard D., Byrne J., and Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. Journal of the National Cancer Institute 90 (1998) 455-460
17. Juni P., Nartey L., Reichenbach S., Sterchi R., Dieppe P.A., and Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 364 (2004) 2021-2029
18. Kagoura M., Yoyoda M., Matsui C., and Morohashi M. Immunohistochemical expression of cyclooxygenase-2 in skin cancers. Journal of Cutaneous Pathology 28 (2001) 298-302
19. Khan K.N., Knapp D.W., Denicola D.B., and Harris R.K. Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. American Journal of Veterinary Research 61 (2000) 478-481
20. Khan K.N., Stanfield K.M., Trajkovic D., and Knapp D.W. Expression of cyclooxygenase-2 in canine renal cell carcinoma. Veterinary Pathology 38 (2001) 116-119
21. Kleiter M., Malarkey D.E., Ruslander D.E., and Thrall D.E. Expression of cyclooxygenase-2 in canine epithelial nasal tumors. Veterinary Radiology and Ultrasound 45 (2004) 255-260
22. Knapp D.W., Glickman N.W., Widmer W.R., DeNicola D.B., Adams L.G., Kuczek T., Bonney P.L., DeGortari A.E., Han C., and Glickman L.T. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemotherapy and Pharmacology 46 (2000) 221-226
23. Lee D.W., Sung M.W., Park S.W., Seong W.J., Roh J.L., Park B., Heo D.S., and Kim K.H. Increased cyclooxygenase-2 expression in human squamous cell carcinomas of the head and neck and inhibition of proliferation by nonsteroidal anti-inflammatory drugs. Anticancer Research 22 (2002) 2089-2096
24. Lin D.T., Subbaramaiah K., Shah J.P., Dannenberg A.J., and Boyle J.O. Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head & Neck 24 (2002) 792-799
25. Lumbers E.R. Development of renal function in the fetus: a review. Reproduction, Fertility and Development 7 (1995) 415-426
26. Maaser K., Daubler P., Barthel B., Heine B., von Lampe B., Stein H., Hoffmeister B., Scherer H., and Scherubl H. Oesophageal squamous cell neoplasia in head and neck cancer patients: upregulation of COX-2 during carcinogenesis. British Journal of Cancer 88 (2003) 1217-1222
27. McEntee M.F., Cates J.M., and Neilsen N. Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Veterinary Pathology 39 (2002) 428-436
28. Mohammed S.I., Bennett P.F., Craig B.A., Glickman N.W., Mutsaers A.J., Snyder P.W., Widmer W.R., DeGortari A.E., Bonney P.L., and Knapp D.W. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Research 62 (2002) 356-358
29. Mohammed S.I., Khan K.N., Sellers R.S., Hayek M.G., DeNicola D.B., Wu L., Bonney P.L., and Knapp D.W. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer. Prostaglandins, Leukotrienes, and Essential Fatty Acids 70 (2004) 479-483
30. Mohammed S.I., Knapp D.W., Bostwick D.G., Foster R.S., Khan K.N., Masferrer J.L., Woerner B.M., Snyder P.W., and Koki A.T. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Research 59 (1999) 5647-5650
31. Patnaik A.K., Liu S.K., Hurvitz A.I., and McClelland A.J. Nonhematopoietic neoplasms in cats. Journal of the National Cancer Institute 54 (1975) 855-860
32. Pestili de Almeida E.M., Piche C., Sirois J., and Dore M. Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs. Journal of Histochemistry and Cytochemistry 49 (2001) 867-875
33. Postorino-Reeves N.C., Turrel J.M., and Withrow S.J. Oral squamous cell carcinoma in the cat. Journal of the American Veterinary Medical Association 29 (1993) 438-441
34. Reddy B.S., and Rao C.V. Chemoprophylaxis of colon cancer. Current Gastroenterology Reports 7 (2005) 389-395
35. Renkonen J., Wolff H., and Paavonen T. Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions. Virchows Archiv 440 (2002) 594-597
36. Sales K.J., Katz A.A., Howard B., Soeters R.P., Millar R.P., and Jabbour H.N. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin E receptors, and angiogenic factors by cyclooxygenase-1. Cancer Research 62 (2002) 424-432
37. Schmidt B.R., Glickman N.W., DeNicola D.B., de Gortari A.E., and Knapp D.W. Evaluation of piroxicam for the treatment of oral squamous cell carcinoma in dogs. Journal of the American Veterinary Medical Association 218 (2001) 1783-1786
38. Shibata M., Kodani I., Osaki M., Araki K., Adachi H., Ryoke K., and Ito H. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncology 41 (2005) 304-312
39. Smith W.L. The eicosanoids and their biochemical mechanisms of action. Biochemical Journal 259 (1989) 315-324
40. Smith W.L., DeWitt D.L., and Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annual Review of Biochemistry 69 (2000) 145-182
41. Sorenmo K.U., Goldschmidt M.H., Shofer F.S., Goldkamp C., and Ferracone J. Evaluation of cyclooxygenase-1 and cyclooxygenase-2 and the effect of cyclooxygenase inhibitors in canine prostatic carcinoma. Veterinary and Comparative Oncology 2 (2004) 13-23
42. Stebbins K.E., Morse C.C., and Goldschmidt M.H. Feline oral neoplasia: a ten-year survey. Veterinary Pathology 26 (1989) 121-128
43. Thun M.J., Namboodiri M.M., and Heath C.W. Aspirin use and reduced risk of fatal colon cancer. New England Journal of Medicine 325 (1991) 1593-1596
44. Tremblay C., Dore M., Bochsler P.N., and Sirois J. Induction of prostaglandin G/H synthase-2 in a canine model of spontaneous prostatic adenocarcinoma. Journal of the National Cancer Institute 91 (1999) 1398-1403
45. Trifan O.C., and Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. Journal of Cellular and Molecular Medicine 7 (2003) 207-222
46. Tucker O.N., Dannenberg A.J., Yang E.K., Zhang F., Teng L., Daly J.M., Soslow R.A., Masferrer J.L., Woerner B.M., Koki A.T., and Fahey III T.J. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Research 59 (1999) 987-990
47. Warner T.D., and Mitchell J.A. Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 13371-13373
48. Wintour E.M., and Moritz K.M. Comparative aspects of fetal renal development. Equine Veterinary Journal 24 Suppl (1997) 51-58
49. Wolff H., Saukkonen K., Anttila S., Karjalainen A., Vainio H., and Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Research 58 (1998) 4997-5001